OMS-1029

N/A

Report date: 2024/11/15 11:10:43

Base Information

Drug NameOMS-1029
Drug Alias NameOMS-1029
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitors
TargetsMannan-binding lectin serine protease 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A